FDA Inspection
Recipharm Pharmaservices Private LimitedRecipharm Pharmaservices Private Limited – FDA Inspection, Feb 13, 2020
Record Details
This FDA Inspection record concerns Recipharm Pharmaservices Private Limited, with an inspection on February 13, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- February 13, 2020
- Product Type
- Drugs
View Company Profile
ID · dd1ea548-d66a-4309-8ac5-8fe1a089153a
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1119410
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 211.68(a)Calibration/Inspection/Checking not done
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Recipharm Pharmaservices Private Limited
8| Date | Classification | Office | Project area |
|---|---|---|---|
| March 22, 2024 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 1, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 7, 2018 | VAI | Office of Inspections and Investigations | Generic Drug Evaluation |
| May 11, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 14, 2017 | Not classified | Office of Inspections and Investigations |
Other documents for Recipharm Pharmaservices Private Limited
- FDA Inspection 1232473 - 2024-03-22
- FDA Inspection 1079034 - 2019-02-01
- FDA Inspection 1075220 - 2018-12-07
- FDA Inspection 1053644 - 2018-05-11
- FDA Inspection 1037690 - 2017-12-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.